| Literature DB >> 24650778 |
Jinghua Wang1, Xin Zhang2, Lili Mu1, Mingqing Zhang1, Zhongming Gao1, Jia Zhang1, Xiuhua Yao1, Chuanliang Liu1, Guangyou Wang1, Dandan Wang1, Qingfei Kong1, Yumei Liu1, Na Li1, Bo Sun3, Hulun Li4.
Abstract
In this study, the capacity for t-PA to affect T cell-brain microvascular endothelial cell adhesion by acting as a cytokine was investigated. Following the treatment of a brain-derived endothelial cell line, bEnd.3, with various concentrations of t-PA, adhesion and transwell migration assays were performed. In the presence of t-PA, enhanced adhesion of T cells to bEnd.3 cells was observed. Using western blot analysis, an increase in ICAM-1 expression was detected for both t-PA-treated bEnd.3 cells and bEnd.3 cells treated with a non-enzymatic form of t-PA. In contrast, when LRP1 was blocked using a specific antibody, upregulation of ICAM-1 was inhibited and cAMP-PKA signaling was affected. Furthermore, using an EAE mouse model, administration of t-PA was associated with an increase in ICAM-1 expression by brain endothelial cells. Taken together, these findings suggest that t-PA can induce ICAM-1 expression in brain microvascular endothelial cells, and this may promote the development of EAE.Entities:
Keywords: Endothelial cells; Experimental autoimmune encephalomyelitis; ICAM-1; LRP1; Tissue-type plasminogen activator
Mesh:
Substances:
Year: 2014 PMID: 24650778 DOI: 10.1016/j.clim.2014.03.004
Source DB: PubMed Journal: Clin Immunol ISSN: 1521-6616 Impact factor: 3.969